[go: up one dir, main page]

WO2012173846A3 - Macrocycles peptidomimétiques - Google Patents

Macrocycles peptidomimétiques Download PDF

Info

Publication number
WO2012173846A3
WO2012173846A3 PCT/US2012/041181 US2012041181W WO2012173846A3 WO 2012173846 A3 WO2012173846 A3 WO 2012173846A3 US 2012041181 W US2012041181 W US 2012041181W WO 2012173846 A3 WO2012173846 A3 WO 2012173846A3
Authority
WO
WIPO (PCT)
Prior art keywords
peptidomimetic macrocycles
macrocycles
disease
peptidomimetic
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2012/041181
Other languages
English (en)
Other versions
WO2012173846A2 (fr
Inventor
Huw M. Nash
Noriyuki Kawahata
Carl Elkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rein Therapeutics Inc
Original Assignee
Aileron Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aileron Therapeutics Inc filed Critical Aileron Therapeutics Inc
Publication of WO2012173846A2 publication Critical patent/WO2012173846A2/fr
Publication of WO2012173846A3 publication Critical patent/WO2012173846A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne de nouveaux macrocycles peptidomimétiques et des procédés d'utilisation de tels macrocycles dans le traitement de maladies.
PCT/US2012/041181 2011-06-06 2012-06-06 Macrocycles peptidomimétiques Ceased WO2012173846A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201161493979P 2011-06-06 2011-06-06
US61/493,979 2011-06-06
US201161494382P 2011-06-07 2011-06-07
US201161494377P 2011-06-07 2011-06-07
US61/494,382 2011-06-07
US61/494,377 2011-06-07

Publications (2)

Publication Number Publication Date
WO2012173846A2 WO2012173846A2 (fr) 2012-12-20
WO2012173846A3 true WO2012173846A3 (fr) 2013-03-21

Family

ID=47357671

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/041181 Ceased WO2012173846A2 (fr) 2011-06-06 2012-06-06 Macrocycles peptidomimétiques

Country Status (1)

Country Link
WO (1) WO2012173846A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2094721B1 (fr) 2006-12-14 2018-02-14 Aileron Therapeutics, Inc. Systèmes de macrocyclisation bis-sulfhydryle
US7981999B2 (en) 2007-02-23 2011-07-19 Aileron Therapeutics, Inc. Triazole macrocycle systems
ES2430067T3 (es) 2007-03-28 2013-11-18 President And Fellows Of Harvard College Polipéptidos cosidos
BRPI0918948A2 (pt) 2008-09-22 2015-12-15 Aileron Therapeutics Inc macrociclos peptidomiméticos
CA2743177A1 (fr) 2008-11-24 2010-05-27 Aileron Therapeutics, Inc. Macrocycles peptidomimetiques avec proprietes ameliorees
CA2744088A1 (fr) 2009-01-14 2010-07-22 Aileron Therapeutics, Inc. Macrocycles peptidomimetiques
CA2774973A1 (fr) 2009-09-22 2011-03-31 Aileron Therapeutics, Inc. Macrocycles peptidomimetiques
PL2603600T3 (pl) 2010-08-13 2019-06-28 Aileron Therapeutics, Inc. Makrocykle peptidomometyczne
CA2852468A1 (fr) 2011-10-18 2013-04-25 Aileron Therapeutics, Inc. Macrocycles peptidomimetiques
HK1205454A1 (en) 2012-02-15 2015-12-18 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
MX362492B (es) 2012-02-15 2019-01-21 Aileron Therapeutics Inc Macrociclos peptidomiméticos.
SG11201503052RA (en) 2012-11-01 2015-05-28 Aileron Therapeutics Inc Disubstituted amino acids and methods of preparation and use thereof
US10905739B2 (en) 2014-09-24 2021-02-02 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and formulations thereof
SG11201702223UA (en) 2014-09-24 2017-04-27 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
AU2016235424A1 (en) 2015-03-20 2017-10-05 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
WO2017004548A1 (fr) 2015-07-01 2017-01-05 Aileron Therapeutics, Inc. Macrocycles peptidomimétiques
US20170056352A1 (en) 2015-08-25 2017-03-02 Rgenix, Inc. PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF
EP3347372A4 (fr) 2015-09-10 2019-09-04 Aileron Therapeutics, Inc. Macrocycles peptidomimétiques en tant que modulateurs de mcl-1
WO2018160178A1 (fr) 2017-03-01 2018-09-07 Rgenix, Inc. Sels pharmaceutiquement acceptables d'acide bêta-guanidinopropionique ayant des propriétés améliorées et utilisations de ceux-ci
AU2020402994A1 (en) 2019-12-11 2022-06-23 Inspirna, Inc. Methods of treating cancer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080262200A1 (en) * 2007-02-23 2008-10-23 Aileron Therapeutics, Inc., A Delaware Corporation Triazole Macrocycle Systems
US20100184047A1 (en) * 2007-03-30 2010-07-22 Oncotherapy Science, Inc. Screening and therapeutic method for nsclc targeting the cdca8-aurkb complex

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080262200A1 (en) * 2007-02-23 2008-10-23 Aileron Therapeutics, Inc., A Delaware Corporation Triazole Macrocycle Systems
US20100184047A1 (en) * 2007-03-30 2010-07-22 Oncotherapy Science, Inc. Screening and therapeutic method for nsclc targeting the cdca8-aurkb complex

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JEYAPRAKASH ET AL.: "Structure of a survivin-borealin-INCENP core complex reveals how chromosomal passengers travel together.", CELL, vol. 131, 2007, pages 271 - 285 *

Also Published As

Publication number Publication date
WO2012173846A2 (fr) 2012-12-20

Similar Documents

Publication Publication Date Title
WO2012173846A3 (fr) Macrocycles peptidomimétiques
HK1205454A1 (en) Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
MX355543B (es) Macrociclos peptidomiméticos.
PH12014501844A1 (en) Peptidomimetic macrocycles
WO2010083347A3 (fr) Macrocycles peptidomimetiques
WO2013059530A3 (fr) Macrocycles peptidomimétiques
MX358886B (es) Macrociclos peptidomimeticos.
HK1202313A1 (en) Methods and compositions for the treatment and diagnosis of bladder cancer
MX342240B (es) Anticuerpos anti-fgfr4 y metodos de uso.
MX2013015311A (es) Polipeptidos de enlace de pcsk9 y metodos de uso.
WO2013056148A3 (fr) Procédés d'utilisation d'antagonistes de scd1
WO2012166626A8 (fr) Réactifs et procédés pour traiter une maladie dentaire
HK1209159A1 (en) Methods of decellularizing bone
MX2014002053A (es) Anticuerpos anti -mcsp y metodos de uso.
WO2014138429A3 (fr) Macrocycles peptidomimétiques et leur utilisation dans la régulation de hif1alpha
PH12014500841B1 (en) ANTI-HtrA1 ANTIBODIES AND METHODS OF USE
HK1198689A1 (en) Antibody formulations and methods
PL2763982T3 (pl) Podstawione benzyloindazole do zastosowania jako inhibitory kinazy Bub1 w leczeniu chorób hiperproliferacyjnych
HK1199100A1 (en) Methods and compositions for the treatment and diagnosis of colorectal cancer
MX2013001473A (es) Anticuerpos contra il-18r1 y usos de los mismos.
MX336323B (es) Anticuerpos de anti-poliubiquitina y metodos de uso.
WO2013023151A3 (fr) Compositions et méthodes de traitement de maladie cœliaque
WO2012106427A3 (fr) Procédés de traitement d'ulcères du pied diabétique
WO2012129299A3 (fr) Instruments médicaux et leurs procédés de fabrication
WO2013106747A3 (fr) Méthodes et compositions pour le traitement et le diagnostic du cancer de la thyroïde

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12800645

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 13/02/2014)

122 Ep: pct application non-entry in european phase

Ref document number: 12800645

Country of ref document: EP

Kind code of ref document: A2